Walleye Capital LLC Amarin Corp Plcuk Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $85,954 - $183,244	-23,614 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $112,874 - $195,051	23,614 New	23,614 $163,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $507,504 - $2.73 Million	-126,876 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $1.77 Million - $3.06 Million	126,876 New	126,876 $2.72 Million

178

65.3M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.